Zoloft PTSD Claim Clears FDA Cmte.; More Studies In Men Sought
Executive Summary
Additional trials of Pfizer's Zoloft (sertraline) in post-traumatic stress disorder should focus on the drug's treatment benefit in men, FDA's Psychopharmacologic Drugs Advisory Committee said Oct. 8. The committee recommended approval of the product for PTSD.